COMMUNIQUÉS West-GlobeNewswire

Merakris Therapeutics Awarded NIH Direct-to-Phase II SBIR Grant to Advance MTX-001 for Diabetic Foot Ulcers
21/07/2026
Award supports a two-year project expected to provide up to $2.2 million in non-dilutive funding while expanding Merakris' clinical-stage pipeline into a second major chronic wound indication RESEARCH TRIANGLE PARK, N.C [...]
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
21/07/2026
Precision testing confirms reproducibility across more than 1,600 tests, three production runs, and three independent testing sites NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
21/07/2026
Company CEO has been a featured presenter at several recent industry events on the emergence of endovascular robotics as expert speaking opportunities raising profile of the Company throughout medtech market HINGHAM, [...]
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
21/07/2026
A Promising Strategy for Improving Production for Applications in Biotechnology Research MELBOURNE, Australia, July 21, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
21/07/2026
Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Standard Dental Labs Announces Acquisition Capital Strategy to Support Next Phase of Florida Expansion
21/07/2026
ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) ("SDL" or the "Company"), a consolidator of dental laboratories throughout Florida, today announced that its Board of Directors [...]
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
21/07/2026
PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, before the [...]
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
21/07/2026
Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- [...]
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
21/07/2026
Initial customer wins bring VivoSim’s human-relevant liver and GI testing to the world’s second-largest pharmaceutical market SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company [...]
Beacon Behavioral Partners Enters Michigan and Ohio Through Partnership with Pure Psychiatry
21/07/2026
Physician-led partnership establishes BBP's first presence in the Midwest, adding a 17-location behavioral health platform, creating a foundation for continued national growth PLANO, Texas, July 21, 2026 (GLOBE NEWSWIRE [...]
PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients
21/07/2026
Partnership combines trusted patient communities with flexible trial participation options to help sponsors enroll faster and retain patients. BOSTON and MORRISVILLE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- [...]
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
21/07/2026
Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary Fibrosis Company on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- [...]
European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity
21/07/2026
PRAGUE and BASEL, Switzerland and BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- SOTIO Biotech , a clinical-stage biopharmaceutical company owned by PPF Group, today announced that the Boards of Appeal of the European Patent [...]
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
21/07/2026
Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patient in Q1 2027 [...]
AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement
21/07/2026
Partnership delivers the real-time status updates and mobile-first engagement today's patients expect from therapy initiation through adherence ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- AssistRx , the advanced [...]
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
21/07/2026
Lonza grants Engitix target-specific license for GlycoConnect ® , HydraSpace ® and SYNtecan E™ linker-payload technologies for ADC development Collaboration enables innovative treatments by combining Lonza’s validated [...]
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
21/07/2026
New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies MIAMI, July 21, 2026 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
21/07/2026
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today [...]
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
21/07/2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announced ASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-centric approach to [...]

Pages